On the other hand, in PAAD, a high expression of TRPM2 was related to poor prognosis only in CD8+ T cells and enriched B cells, but showed no statistically significant difference (Figure 6B). The gene discussed is TRPM2; the disease is pancreatic adenocarcinoma.